FDA Guidance Documents·· 原文未提供具体时分
Process for Handling Referrals to FDA Under 21 CFR 50.54 - Additional Safeguards for Children in Clinical Investigations: Guidance for Clinical Investigators, Institutional Review Boards and Sponsors
Process for Handling Referrals to FDA Under 21 CFR 50.54 - Additional Safeguards for Children in Clinical Investigations: Guidance for Clinical Investigators, Institutional Review Boards and Sponsors
AI 导读
FDA 官方历史目录记录；Final guidance；发布日期：2006-12-01。官方主题：Good Clinical Practice (GCP), Pediatric Product Development。请通过官方原文与附件查阅文件。
来源：FDA Guidance Documents · fda.gov